The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics, Inc. | Common Stock | 008064107 | 59,113,365 | 2,017,521 | SH | SOLE | 2,017,521 | 0 | 0 | |||
Akero Therapeutics, Inc. | Common Stock | 00973Y108 | 32,564,955 | 594,251 | SH | SOLE | 594,251 | 0 | 0 | |||
AVROBIO INC | Common Stock | 05455M100 | 3,222,923 | 4,520,863 | SH | SOLE | 4,520,863 | 0 | 0 | |||
Day One Biopharmaceuticals, Inc. | Common Stock | 23954D109 | 162,870,182 | 7,568,317 | SH | SOLE | 7,568,317 | 0 | 0 | |||
Disc Medicine, Inc. | Common Stock | 254604101 | 68,854,884 | 3,461,784 | SH | SOLE | 3,461,784 | 0 | 0 | |||
Dyne Therapeutics, Inc. | Common Stock | 26818M108 | 114,387,308 | 9,869,483 | SH | SOLE | 9,869,483 | 0 | 0 | |||
F-star Therapeutics, Inc. | Common Stock | 30315R107 | 3,788,992 | 599,524 | SH | SOLE | 599,524 | 0 | 0 | |||
Generation Bio, Co. | Common Stock | 37148K100 | 32,535,983 | 8,278,876 | SH | SOLE | 8,278,876 | 0 | 0 | |||
Ikena Oncology, Inc. | Common Stock | 45175G108 | 13,348,353 | 5,018,178 | SH | SOLE | 5,018,178 | 0 | 0 | |||
Kymera Therapeutics, Inc. | Common Stock | 501575104 | 149,379,011 | 5,984,736 | SH | SOLE | 5,984,736 | 0 | 0 | |||
MAGENTA THERAPEUTICS INC | Common Stock | 55910K108 | 1,373,232 | 3,476,536 | SH | SOLE | 3,476,536 | 0 | 0 | |||
Replimune Group, Inc. | Common Stock | 76029N106 | 57,073,760 | 2,098,300 | SH | SOLE | 2,098,300 | 0 | 0 | |||
SPERO THERAPEUTICS INC | Common Stock | 84833T103 | 1,783,907 | 1,031,160 | SH | SOLE | 1,031,160 | 0 | 0 | |||
Third Harmonic Bio, Inc. | Common Stock | 88427A107 | 46,903,794 | 10,907,859 | SH | SOLE | 10,907,859 | 0 | 0 | |||
Vigil Neuroscience, Inc. | Common Stock | 92673K108 | 72,960,925 | 5,836,874 | SH | SOLE | 5,836,874 | 0 | 0 | |||
Viridian Therapeutics, Inc. | Common Stock | 92790C104 | 2,631,003 | 90,072 | SH | SOLE | 90,072 | 0 | 0 | |||
Xilio Therapeutics, Inc. | Common Stock | 98422T100 | 7,422,635 | 2,759,344 | SH | SOLE | 2,759,344 | 0 | 0 |